The aim of this study was to examine the relationship between substanc
e abuse and tardive diskinesia (TD) in 51 chronic, neuroleptic-treated
, community outpatients with a DSM-III-R diagnosis of schizophrenia. I
n the presence of a clinical researcher, subjects completed a question
naire on past and current alcohol and drug use, and provided informati
on pertaining to variables which have, in the past, been implicated in
the development of TD: smoking habits, caffeine consumption, and curr
ent neuroleptic dose. Subjects were also administered the Abnormal Inv
oluntary Movement Scale (AIMS) in an interview format with either two
or three trained raters present in the room. Consistent with previous
reports, our results indicated a trend for females and older patients
with a longer duration of illness to show elevated scores on the AIMS.
In a hierarchical multiple regression analysis, however, cannabis use
was found to correlate best with the presence of TD, outranking other
putative factors.